Previous year, EUROIMMUN launched the Anti-Zika Virus ELISA IgA. It had turned out that specific anti-Zika virus IgA antibodies against the non-structural protein 1 (NS1) could serve as alternative indicators of acute infection phase if specific IgM antibodies were not detectable. Particularly when patients, who already have had a first contact with a flavivirus (infection […]
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar on February 15th, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS addressed the current epidemiologic status of measles and mumps, challenges and solutions in serological testing,
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS address the current epidemiologic status of measles and mumps, challenges and solutions in serological testing, perspectives in vaccine
Approximately every fifth person in Europe and almost all adults in large parts of Asia are not able to digest lactose. This is referred to as lactose intolerance. Actually, lactose intolerance is not a disease, but the natural state in mammals. After weaning, the activity of the digestive enzyme lactase, which splits lactose into the
In December 2017, the German Society for Rheumatology (DGRh) published their first guideline for the diagnosis and treatment of ANCA-associated forms of vasculitis (AAV) [1]. The AAV encompass granulomatosis with polyangiitis (GPA, formerly Wegener’s granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome), which all occur with autoantibodies against cytoplasmic antigens
